TP53 and breast cancer: To evaluate the effects of p53 mutant reactivation in the setting of Brca1 loss, we examined the effect of ZMC1 in mouse models of Brca1-deficient mammary cancer that harbor either the zinc-binding deficient p53R172H (mouse equivalent of human p53R175H) or a p53-null mutation.